vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.
Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $83.5M, roughly 1.1× BillionToOne, Inc.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 2.3%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...
BLLN vs PACK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $93.7M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | 39.0% |
| Operating Margin | 11.5% | -1.0% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | 2.3% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $93.7M | ||
| Q3 25 | $83.5M | $83.6M | ||
| Q2 25 | — | $77.8M | ||
| Q1 25 | — | $77.6M | ||
| Q4 24 | — | $91.6M | ||
| Q3 24 | $38.4M | $78.6M | ||
| Q2 24 | — | $72.8M | ||
| Q1 24 | — | $72.5M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $-10.4M | ||
| Q2 25 | — | $-7.5M | ||
| Q1 25 | — | $-10.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.9M | $-8.1M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $-8.1M |
| Q4 25 | — | 39.0% | ||
| Q3 25 | 69.9% | 41.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 45.2% | ||
| Q3 24 | 52.6% | 43.8% | ||
| Q2 24 | — | 43.5% | ||
| Q1 24 | — | 44.6% |
| Q4 25 | — | -1.0% | ||
| Q3 25 | 11.5% | -6.8% | ||
| Q2 25 | — | -12.5% | ||
| Q1 25 | — | -10.3% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | -32.9% | -5.3% | ||
| Q2 24 | — | -7.1% | ||
| Q1 24 | — | -6.6% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | -12.4% | ||
| Q2 25 | — | -9.6% | ||
| Q1 25 | — | -14.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | -10.3% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | -11.2% |
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $0.10 | $-0.12 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.13 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-1.47 | $-0.10 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $63.0M |
| Total DebtLower is stronger | $55.0M | $401.9M |
| Stockholders' EquityBook value | $-239.5M | $534.9M |
| Total Assets | $327.5M | $1.1B |
| Debt / EquityLower = less leverage | — | 0.75× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $63.0M | ||
| Q3 25 | $195.2M | $49.9M | ||
| Q2 25 | — | $49.2M | ||
| Q1 25 | — | $65.5M | ||
| Q4 24 | — | $76.1M | ||
| Q3 24 | — | $69.5M | ||
| Q2 24 | — | $65.1M | ||
| Q1 24 | — | $55.1M |
| Q4 25 | — | $401.9M | ||
| Q3 25 | $55.0M | $403.1M | ||
| Q2 25 | — | $403.1M | ||
| Q1 25 | — | $405.2M | ||
| Q4 24 | — | $406.4M | ||
| Q3 24 | — | $403.2M | ||
| Q2 24 | — | $396.1M | ||
| Q1 24 | — | $396.7M |
| Q4 25 | — | $534.9M | ||
| Q3 25 | $-239.5M | $537.8M | ||
| Q2 25 | — | $539.0M | ||
| Q1 25 | — | $544.1M | ||
| Q4 24 | — | $548.1M | ||
| Q3 24 | $-242.9M | $564.3M | ||
| Q2 24 | — | $566.2M | ||
| Q1 24 | — | $560.0M |
| Q4 25 | — | $1.1B | ||
| Q3 25 | $327.5M | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.71× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $19.5M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $19.5M | ||
| Q3 25 | $13.8M | $8.5M | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | $-1.3M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $10.1M | ||
| Q2 24 | — | $19.6M | ||
| Q1 24 | — | $5.2M |
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.56× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
